<?xml version="1.0" encoding="UTF-8"?>
<p id="p0295">
 <list list-type="simple" id="ulist0055">
  <list-item id="u0160">
   <label>•</label>
   <p id="p0300">Consider early admission according to the presence of additional risk factors and inclusion in clinical trials and (experimental) antiviral therapy of COVID-19 following local guidelines (see 
    <xref rid="tbl1" ref-type="table">Table 1</xref> for guidance with regards to CLD)
   </p>
  </list-item>
  <list-item id="u0165">
   <label>•</label>
   <p id="p0305">Prevent acetaminophen overdosing (2–3 g/day is considered safe in patients with cirrhosis without active alcohol consumption
    <xref rid="bib33" ref-type="bibr">
     <sup>33</sup>
    </xref>)
   </p>
  </list-item>
  <list-item id="u0170">
   <label>•</label>
   <p id="p0310">Do not administer non-steroidal anti-inflammatory drugs in patients with cirrhosis and portal hypertension
    <xref rid="bib33" ref-type="bibr">
     <sup>33</sup>
    </xref>
   </p>
  </list-item>
  <list-item id="u0175">
   <label>•</label>
   <p id="p0315">See also section on “
    <xref rid="sec10" ref-type="sec">liver-related diagnostic procedures</xref>” for recommendations on endoscopy, HCC surveillance and liver biopsy
   </p>
  </list-item>
 </list>
</p>
